By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tenax Therapeutics (Formerly Known As Oxygen Biotherapeutics, Inc.) 

3189 Airway Avenue, Building C

Costa Mesa  California  92626  U.S.A.
Phone: 800-809-6054 Fax: 714-427-6361


SEARCH JOBS








Company News
Tenax Therapeutics (TENX) Announces First Quarter Fiscal Year 2015 Financial Results 9/24/2014 9:05:27 AM
Tenax Therapeutics Announces First Patients Enrolled In Phase 3 LEVO-CTS Clinical Trial Of Levosimendan 9/22/2014 10:34:54 AM
Tenax Therapeutics To Provide Corporate Update And Discuss First Quarter Fiscal Year 2015 Financial Results On September 24, 2014 9/19/2014 8:23:24 AM
Oxygen Biotherapeutics, Inc. Announces Name Change To Tenax Therapeutics 9/16/2014 8:54:32 AM
Oxygen Biotherapeutics, Inc. (OXBT) Shares Gyrate After Halting Mid-Stage Brain Injury Trial 9/11/2014 4:05:41 PM
Oxygen Biotherapeutics, Inc. (OXBT) To Present At Wedbush 2014 Life Sciences Management Access Conference 8/8/2014 9:04:59 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014 9:25:25 AM
Oxygen Biotherapeutics, Inc. (OXBT) Announces Fiscal Year 2014 Financial Results 7/29/2014 9:42:20 AM
Oxygen Biotherapeutics, Inc. (OXBT) To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On July 29, 2014 7/23/2014 1:33:43 PM
Oxygen Biotherapeutics, Inc. (OXBT) Release: Recent Scientific Publications Highlight Potential Benefits Of Levosimendan In Cardiac Surgery And Additional Critical Care Conditions 7/9/2014 10:54:48 AM
12345678910...
//-->